CStone Pharmaceuticals
CSPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$91,207 | -$367,234 | -$902,678 | -$1,920,100 |
| Dep. & Amort. | $49,805 | $58,190 | $44,540 | $22,661 |
| Deferred Tax | $0 | $0 | $0 | $134,235 |
| Stock-Based Comp. | -$2,811 | $36,993 | $142,062 | $222,671 |
| Change in WC | -$302,800 | -$139,666 | $72,647 | $64,520 |
| Other Non-Cash | $3,832 | -$177,126 | $30,960 | -$8,011 |
| Operating Cash Flow | -$343,181 | -$588,843 | -$612,469 | -$1,484,024 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$15 | -$101,821 | -$149,136 |
| Net Acquisitions | $0 | $0 | $0 | -$48,418 |
| Inv. Purchases | -$255,000 | -$67,778 | -$683,407 | -$1,051,017 |
| Inv. Sales/Matur. | $866 | $515,472 | $1,147,215 | $363,538 |
| Other Inv. Act. | $6,455 | $171,926 | $3,132 | $58,481 |
| Investing Cash Flow | -$247,679 | $619,605 | $365,119 | -$826,552 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$786 | $91,433 | $37,746 | $89,509 |
| Stock Issued | $74 | $341,824 | $2,529 | $16,830 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$12,184 | -$44,902 | -$11,808 | -$14,035 |
| Financing Cash Flow | -$12,896 | $388,355 | $28,467 | $92,304 |
| Forex Effect | -$4,978 | $18,870 | $34,843 | -$63,552 |
| Net Chg. in Cash | -$608,734 | $437,987 | -$184,040 | -$2,281,824 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $996,671 | $558,684 | $742,724 | $3,024,548 |
| End Cash | $387,937 | $996,671 | $558,684 | $742,724 |
| Free Cash Flow | -$343,181 | -$653,890 | -$714,290 | -$1,633,160 |